Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1992-07-13
1995-08-08
Wax, Robert A.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
435 691, 4351723, 4353201, 4352523, 4352401, 43525411, 536 232, 536 234, 935 10, 935 14, C12N 922, C12N 1555, C12N 121, C12N 510, C12N 115
Patent
active
054398150
ABSTRACT:
Ribotoxins, such as restrictocin, mitogillin and alpha-sarcin which do not contain a cysteine for linkage to antibodies for immunotoxin production need to be modified for such linkage without compromising biological activity. Protein analogues of such native ribotoxins are provided in which both the analogue and the native ribotoxin can cleave only a single phosphodiester bond of 28S rRNA in a 60S ribosomal subunit and in which the analogue comprises only one cysteine available from covalent linkage to a partner, such as an antibody, which cysteine is not present in the native ribotoxin. Especially preferred analogues are restrictocin Cys 13, Cys 82, Cys 106 and Cys 110 and restrictocin Cys 150-Gly151. Corresponding DNA sequences, vectors, host cells, immunotoxins and pharmaceutical compositions are also claimed.
REFERENCES:
patent: 3104204 (1963-09-01), Olson et al.
patent: 3104208 (1963-09-01), Olson et al.
patent: 4340535 (1982-07-01), Voisin et al.
patent: 4753894 (1988-06-01), Frankel et al.
Hird et al. (1990) in Genes & Cancer, Carney et al (ed) New York: Wiley & Sons, pp. 183-189.
Osband et al (1990) Immunol. Today, 11:193-195.
Harris et al. (1993) Tibtech II:42-44.
Oka et al., Nucleic Acids Research, vol. 18, No. 7, p. 1897, 1990; "Complete nucleotide sequence of cDNA for . . . ".
Orlandi et al., Cancer Immunology Immunotherapy, vol. 26, p. 114-120, 1988; "Immunoconjugate generation between . . . ".
Conde et al., Journal of Cellular Biochemistry, Supp. 10B, abstract G83, p. 77, 1986; "Immunotoxins generated . . . ".
Lyons et al., Protein Engineering, vol. 3, No. 8, pp. 703-708, 1990; "Site-specific attachment to recombinant antibodies . . . ".
Better et al., The Journal of Biological Chemistry, vol. 267, No. 234, 1992; "Activity of Recombinant Mitogillin . . . ".
Munoz et al., Biochemical and Biophysical Research Communications, vol. 173, No. 2, pp. 554-560, 1990.
Wawrzynczak et al., European Journal of Biochemistry, vol. 196, pp. 203-209, 1991; "Biochemical, cytotoxic . . . ".
Stirpe et al., FEBS Letters, vol. 195, No. 1, 2, pp. 1-8, 1986; "Ribosome-inactivating proteins up to date".
Carter et al., Science, vol. 237, pp. 394-399, 1987; "Engineering Enzyme Specificity by `Substrate-Assisted Catalysis`".
Ljungquist et al., European Journal of Biochemistry, vol. 186, pp. 557-561, 1989; "Thiol-directed immobilization . . . ".
Scott et al., JNCI, vol. 79, No. 5, 1987; "An Immunotoxin Composed of a Monoclonal Antitransferrin Receptor . . . ".
Arruda et al., Journal of Experimental Medicine, vol. 172, pp. 1529-1532, 1990; "Aspergillus fumigatus Allergen I . . . ".
Yang et al, Gembank, EMBL databases; accession #'s M65257, M55508; May 20, 1991; Sequence encoding restrictocin.
Bernhard et al, Enhanced Potency of Antibody Conjugates With Toxin Analogs Of Gelonin, Brip and Mitogillin, Program and Abstracts Third International Symposium of Immunotoxins, Jun. 19-21, 1992.
Better et al, Generation of Potent Immunoconjugates from Microbially Produced Fab', F(ab').sub.2, and antibody-toxin gene fusions, Program and Abstracts Third International Symposium On Immunotoxins, Jun. 19-21, 1992.
Brigotti et al, Effect of .alpha.-sarcin and ribosome-inactivating proteins on the interaction of elongation factors with ribosomes, Biochem. J. vol. 257, 1989, pp. 723-727.
Conde et al, The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells, Eur. J. Biochem., vol. 178, 1989, pp. 795-802.
Conde et al, Protein Toxins That Catalytically Inactivate Ribosomes From Eukaryotic Microorganisms Studies On The Mode Of Action Of Alpha Sarcin, Mitogillin And Restrictocin: Response To Alpha Sarcin Antibodies, FEMS Microbiology Letters, vol. 4, 1978, pp. 349-355.
Endo et al, The Site of Action .alpha.-Sarcin on Eurkaryotic Ribosomes--The Sequence at the .alpha.-Sarcin Cleavage Site in 28 S Ribosomal Ribonucleic Acid, The Journal of Biological Chemistry, vol. 257, No. 15, Aug. 1982, pp. 9054-9060.
Endo et al, The Ribonuclease Activity of the Cytotoxin .alpha.-Sarcin, The Journal of Biological Chemistry, vol. 258, No. 4, Issue of Feb. 25, 1983, pp. 2662-2667.
Fando et al, The Mode Of Action Of Restriction And Mitogillin On Eukaryotic Ribosomes--Inhibition of brain protein synthesis, cleavage and sequence of the ribosomal RNA fragment; J. Biochem., vol. 149, 1985, pp. 29-34.
Fernandez-Luna et al, Complete Amino Acid Sequence of the Aspergillus Cytrotoxin Mitogillin Biochemistry, vol. 24, 1985, pp. 861-867.
Gavilanes et al, Chemical and Spectroscopic Evidence on the Homology of Three Antitumor Proteins: .alpha.-Sarcin, Mitogillin, and Restrictocin, Journal of Protein Chemistry, vol. 2, No. 3, 1983, pp. 251-261.
Hatfull et al, Preparation of Heavy-atom Derivatives Using Site-directed Mutagenesis, J. Mol. Biol., vol. 208, 1989, pp. 661-667.
Henze et al., Expression of the Chemically Synthesized Coding Region for the Cytotoxin .alpha.-sarcin in Escherichia coli using a Secretion Cloning Vector, Eur. J. Biochem, vol. 192, 1990, pp. 127-131.
Hobden et al, The Mode of Action of Alpha Sarcin and a Novel Assay of the Puromycin Reaction, Biochem. J., vol. 170, 1978, pp. 57-61.
Lamy et al, Isolation and Nucleotide Sequence of the Aspergillus Restrictus Gene Coding for the Ribonucleolytic Toxin Restrictocin and its Expression in Aspergillus nidulans: The Leader Sequence Protects Producing Strains From Suicide, Nucleic Acids Research, vol. 19, No. 5, 1001-1006 (1991).
Lopez-Otin et al, The Primary Structure of the Cytotoxin Restictocin, Eur. J. Biochem. 143, (1984), pp. 621-634.
Lyons et al, Site-specific Attachment to Recombinant Antibodies Via Introduced Surface Cysteine Residues, Protein Engineering, vol. 3, No. 8, 1990, pp. 703-708.
Miller et al, The Ribosomes of Aspergillus giganteus are Sensitive to the Cytotoxic action of .alpha.-sarcin, FEB 05666, vol. 229, No. 2, 1988, pp. 388-390.
Munoz et al, Fractionation of the Ribosome Inactivating Protein Preparations with Triazine Dyes, Biochemical and Biophysical Research Communications, vol. 173, No. 2, 1990, pp. 554-560.
Olson et al, Alpha Sarcin, A New Antitumor Agent, Applied Microbiology, vol. 13, No. 3, 1965, pp. 314-321.
Olson et al, Alpha Sarcin, A New Antitumor Agent, Applied Microbiology, vol. 13, No. 3, 1965, pp. 322-326.
Orlandi et al, Immunoconjugate Generation Between the Ribosome Inactivating Protein Restrictocin and an Anti-human Breast Carinoma MAB, Cancer Immunol. Immunother. vol. 26, 1988, pp. 114-120.
Martinez del Pozo et al, Conformational Study of the Antitumor Protein .alpha.-Sarcin, Biochimica et Biophysica Acta vol. 953, 1988, pp. 280-288.
Rodriguez et al, Amino Acid Sequence homologies in Alfa-Sarcin, Restrictocin and Mitogillin, Biochemical and Biophysical Research Communications, vol. 108, No. 1, 1982, pp. 315-321.
Sacco et al, The Primary Structure of the Cytotoxin .alpha.-Sarcin, The Journal of Biological Chemistry, vol. 2, No. 9, 1983, pp. 5811-5818.
Sanz et al, Sensitivity of Thermoacidophilic Archaebacteria to .alpha.-sarcin, FEBS 1487, vol. 171, No. 1, 1984, pp. 63-66.
Schindler et al, Specific Cleavage of Ribosomal RNA caused by Alpha Sarcin, Nucleic Acids Research, vol. 4, No. 4, 1977, pp. 1097-1111.
Singh et al, Effects of Thiolation on the Immunoreactivity of the Ribosome-inactivating Protein Gelonin, Biochem. J., vol. 263, 1989, pp. 417-423.
Sperti et al, Alpha-Sarcin Impairs the N-Glycosidase Activity of Ricin on Ribosomes, Biochemical and Biophysical Research Communications, vol. 160, No. 2, 1989, pp. 857-861.
Wool, The Mechanism of Action of the Cytotoxic Nuclease .alpha.-sarcin and its use to Analyse Ribosome Structure, TIBS, 1984, pp. 14-17.
Fitton John E.
Timms David
Bugaisky G. E.
Imperial Chemical Industries plc
Wax Robert A.
LandOfFree
Restrictocin-like ribotoxin analogues comprising only one cystei does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Restrictocin-like ribotoxin analogues comprising only one cystei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Restrictocin-like ribotoxin analogues comprising only one cystei will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-970623